| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.542 | 57.618 | 66.765 | 60.264 | 18.513 | 11.303 | 16.146 | 14.407 | 19.799 | 22.586 |
| Total Income - EUR | 50.542 | 57.639 | 66.812 | 60.268 | 18.523 | 11.303 | 16.146 | 14.453 | 19.840 | 22.586 |
| Total Expenses - EUR | 64.088 | 73.200 | 42.163 | 42.834 | 29.731 | 16.707 | 12.061 | 27.119 | 32.083 | 26.308 |
| Gross Profit/Loss - EUR | -13.546 | -15.561 | 24.649 | 17.434 | -11.208 | -5.403 | 4.084 | -12.666 | -12.243 | -3.722 |
| Net Profit/Loss - EUR | -15.062 | -17.291 | 20.934 | 15.632 | -11.764 | -5.609 | 3.840 | -13.013 | -12.243 | -3.722 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Alergofag Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.602 | 28.120 | 17.540 | 6.721 | 546 | 230 | 409 | 0 | 0 | 0 |
| Current Assets | 61.724 | 2.668 | 19.862 | 34.414 | 20.816 | 11.418 | 12.294 | 1.827 | 312 | 638 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 164 | 59 | 0 | 0 | 0 |
| Receivables | 0 | 1.665 | 2 | 5 | 12 | 2 | 0 | 681 | 233 | 232 |
| Cash | 61.724 | 1.002 | 19.859 | 34.409 | 20.804 | 11.252 | 12.235 | 1.146 | 79 | 406 |
| Shareholders Funds | 52.498 | -10.962 | 10.158 | 25.604 | 13.345 | 7.483 | 11.157 | -1.822 | -14.059 | -17.703 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 48.829 | 41.750 | 27.244 | 15.530 | 8.018 | 4.164 | 1.547 | 3.649 | 14.371 | 18.341 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergofag Srl